QA: Acer Therapeutics Inc in us_pharma/2014

Table of Contents

See also this year's filing and all EDGAR filings for this company.

PDF Report 0001069308_2015_Acer_Therapeutics_Inc.pdf

Logs

warning The stock price does not exist industry.us_generic {}
warning Ignoring company because Expenses is zero pre-agg {'balance_sheet': {'company_id': '0001069308', 'EntityCommonStockSharesOutstanding': 6864340, 'Assets': 14416698, 'AssetsCurrent': 13578831, 'CostOfGoodsAndServicesSold': 0, 'Expenses': 0, 'IntangibleAssetsNetIncludingGoodwill': 0, 'Liabilities': 4801436, 'LiabilitiesAndStockholdersEquity': 14416698, 'LiabilitiesCurrent': 4801436, 'LiabilitiesNoncurrent': 0, 'NetIncome': -12019278, 'PropertyPlantAndEquipmentNet': 837867, 'ResearchAndDevelopmentExpense': 0, 'Revenues': 0, 'SellingGeneralAndAdministrativeExpense': 0, 'remainder_Assets': 0, 'remainder_ComprehensiveNetIncome': 0, 'remainder_Expenses': 0, 'remainder_Liabilities': 0, 'remainder_LiabilitiesAndStockholdersEquity': 9615262, 'remainder_NetIncome': -12019278, 'remainder_Revenues': 0, 'obs_EconomicCapitalRatio': nan}}

Graph

Absolute values for 0001069308, Acer Therapeutics Inc

  xvar xval
0 AssetsCurrent 10,665,316
1 IntangibleAssetsNetIncludingGoodwill 0
2 PropertyPlantAndEquipmentNet 1,098,104
3 remainder_Assets 38,939
4 LiabilitiesCurrent 3,132,424
5 LiabilitiesNoncurrent 0
6 remainder_Liabilities 1,230,748
7 CostOfGoodsAndServicesSold 0
8 SellingGeneralAndAdministrativeExpense 0
9 ResearchAndDevelopmentExpense 0
10 remainder_Expenses 1,983
11 remainder_Revenues 0
12 remainder_NetIncome -15,050,280
13 remainder_ComprehensiveNetIncome 0
  yvar yval
0 Assets 11,802,359
1 Liabilities 4,363,172
2 Expenses 1,983
3 Revenues 0
4 StockholdersEquity 7,439,187
5 NetIncome -15,052,263
6 ComprehensiveNetIncome -15,052,263
7 BaseVar 15,608,897
8 EconomicCapitalRatiobeforeLimitedLiability 0.144
9 EconomicCapitalRatio 1.55

Edgar->Model Mapping

Feature Distribution

Change over Time